Of interest to note is that regular treatment of MS patients with steroids, IFN-β or glatiramer acetate raised serum levels of IL-1ra [59], [120]–[122] and IFN-β, and also enhances microglial production of IL-1ra [123]. The gene discussed is IFNB1; the disease is myeloid sarcoma.